 | ||||||
| "anti diabetes" | ||||||
| NEWS | ||||||
| Novo Nordisk Is Being Ignored Novo Nordisk (OCSE:NOVO B), the $106.9 billion pharmaceutical giant, delivered its first fiscal 2016 earnings on Aug. 5 with a sales and profit growth ...
| ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.